DSCC1 and neoplasm: Amplification of 8q24.11-13 (THRAP6, DCC1, SQLE, SPG8) and 11q14.1 (NDUFC2, ALG8, USP35) have been associated with poor prognosis in a novel subtype of high-grade ER- tumors [36].